PNS246 EMA G-BA - A COMPARISON OF TIME LIMITATIONS OF EUROPEAN MARKETING AUTHORIZATIONS AND GERMAN ADDED BENEFIT ASSESSMENTS FOR NEW PHARMACEUTICALS.
Nov 1, 2019, 00:00
10.1016/j.jval.2019.09.2146
https://www.valueinhealthjournal.com/article/S1098-3015(19)34524-3/fulltext
Title :
PNS246 EMA G-BA - A COMPARISON OF TIME LIMITATIONS OF EUROPEAN MARKETING AUTHORIZATIONS AND GERMAN ADDED BENEFIT ASSESSMENTS FOR NEW PHARMACEUTICALS.
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(19)34524-3&doi=10.1016/j.jval.2019.09.2146
First page :
Section Title :
Open access? :
No
Section Order :
11862